Patients with 8 micturitions/24h and 1 urgency episode/24h or 1 urgency incontinence episode/24h were randomised to once-daily placebo , mirabegron 50mg or tolterodine 4mg ( as an active comparator , without testing for non-inferiority of efficacy and safety ) for 12 weeks .